|
Neoplasia
Citations 1-10 of 4220 total displayed.
|
Most recent content
(1 Jan 2009):
|
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, Roberta Mortarini, Serenella M. Pupa, Michele Magni, Liliana Devizzi, Paola Matteucci, Paola Baldassari, Fernando Ravagnani, Antonello Cabras, Andrea Anichini, and Alessandro M. Gianni
Blood 2009; 113: 18-27.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 1997):
|
Stem cell concepts renew cancer research
- John E. Dick
Blood 2008; 112: 4793-4807.
[Abstract]
[Full text]
[PDF]
Translation of the Philadelphia chromosome into therapy for CML
- Brian J. Druker
Blood 2008; 112: 4808-4817.
[Abstract]
[Full text]
[PDF]
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
- Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean-François Rossi, Corinne Haioun, Pauline Brice, Béatrice Mahé, Reda Bouabdallah, Bruno Audhuy, Christophe Ferme, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, and Charles Foussard
Blood 2008; 112: 4824-4831.
[Abstract]
[Full text]
[PDF]
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
- Rob Pieters, Inge Appel, Hans-Juergen Kuehnel, Iris Tetzlaff-Fohr, Uwe Pichlmeier, Inekee van der Vaart, Eline Visser, and Rolinda Stigter
Blood 2008; 112: 4832-4838.
[Abstract]
[Full text]
[PDF]
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
- Elias Jabbour, Hagop M. Kantarjian, Dan Jones, Neeli Reddy, Susan O'Brien, Guillermo Garcia-Manero, Jan Burger, and Jorge Cortes
Blood 2008; 112: 4839-4842.
[Abstract]
[Full text]
[PDF]
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
- David C. Johnson, Sophie Corthals, Christine Ramos, Antje Hoering, Kim Cocks, Nicholas J. Dickens, Jeff Haessler, Harmut Goldschmidt, J. Anthony Child, Sue E. Bell, Graham Jackson, Dalsu Baris, S. Vincent Rajkumar, Faith E. Davies, Brian G. M. Durie, John Crowley, Pieter Sonneveld, Brian Van Ness, and Gareth J. Morgan
Blood 2008; 112: 4924-4934.
[Abstract]
[Full text]
[PDF]
Angiostatic activity of the antitumor cytokine interleukin-21
- Karolien Castermans, Sebastien P. Tabruyn, Rong Zeng, Judy R. van Beijnum, Cheryl Eppolito, Warren J. Leonard, Protul A. Shrikant, and Arjan W. Griffioen
Blood 2008; 112: 4940-4947.
[Abstract]
[Full text]
[PDF]
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- Erik A. Nelson, Sarah R. Walker, Alicia Kepich, Laurie B. Gashin, Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Kenneth C. Anderson, and David A. Frank
Blood 2008; 112: 5095-5102.
[Abstract]
[Full text]
[PDF]
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor–CD3 expression in enteropathy-associated T-cell lymphoma
- Jennifer M. L. Tjon, Wieke H. M. Verbeek, Yvonne M. C. Kooy-Winkelaar, Binh H. Nguyen, Arno R. van der Slik, Allan Thompson, Mirjam H. M. Heemskerk, Marco W. J. Schreurs, Liesbeth H. A. Dekking, Chris J. Mulder, Jeroen van Bergen, and Frits Koning
Blood 2008; 112: 5103-5110.
[Abstract]
[Full text]
[PDF]
|
|
